Assessment of Breathing Using an Under-bed Weighing Scale
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04736212 |
|
Recruitment Status :
Recruiting
First Posted : February 3, 2021
Last Update Posted : September 24, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The aim of this study is to assess the capability of a modified under bed weighing scale (contact-free unconstrained respiratory monitor, BSS) to predict postoperative pulmonary complications in high-risk surgical patients.
The study is designed to test the hypothesis that abnormal breathing measured by a modified under bed weighing scale predicts postoperative pulmonary complications within 7 days after surgery.
| Condition or disease | Intervention/treatment |
|---|---|
| Postoperative Respiratory Complication Respiratory Failure | Device: Bed sensor monitoring system |
| Study Type : | Observational |
| Estimated Enrollment : | 150 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Assessment of Breathing Using an Under-bed Weighing Scale |
| Actual Study Start Date : | March 24, 2021 |
| Estimated Primary Completion Date : | March 1, 2022 |
| Estimated Study Completion Date : | October 1, 2022 |
- Device: Bed sensor monitoring system
Respiratory patterns in the post-anesthesia care unit will be assessed using a validated, modified under bed weighing scale placed under the patient's bed in the PACU.
- Postoperative pulmonary complications [ Time Frame: First 7 postoperative days ]atelectasis, pneumonia, acute respiratory distress syndrome, pulmonary aspiration, re-intubation, unprecedented non-invasive ventilation, unplanned ICU admission, or re-admission to the hospital due to respiratory complication.
- Postoperative pulmonary complications [ Time Frame: First 3 postoperative days ]atelectasis, pneumonia, acute respiratory distress syndrome, pulmonary aspiration, re-intubation, unprecedented non-invasive ventilation, unplanned ICU admission, or re-admission to the hospital due to respiratory complication.
- Major adverse Cardiovascular events [ Time Frame: First 7 postoperative days ]death, myocardial infarction, coronary revascularization, stroke, and heart failure.
- Hospital length of stay [ Time Frame: 30 days after surgery ]Duration from surgery to hospital discharge
- Adverse discharge disposition [ Time Frame: 30 days after surgery ]lost of ability to live independently: adverse discharge disposition to a skilled nursing facility or in-hospital mortality
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Age 18 years or older
- Undergoing non-cardiac surgery under general anesthesia.
- Score ≥ 25 in the risk prediction score (Table1)
Exclusion Criteria:
- Ambulatory (outpatient) surgery
- Transfer directly to the ICU
- Remain intubated/ planned to remain intubated after surgery
- Pregnant patients: as detected by patient self-reporting of diagnosed by preoperative pregnancy testing according to institutional policies at BIDMC.
- Patients enrolled in other interventional studies which could confound the primary endpoint.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04736212
| Contact: Maximilian Schaefer, M.D. | 617-667-3112 | msschaef@bidmc.harvard.edu |
| United States, Massachusetts | |
| Beth Israel Deaconess Medical Center | Recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: Maximilian S Schaefer, MD 617-632-0728 msschaef@bidmc.harvard.edu | |
| Responsible Party: | Maximilian S Schaefer, Assistant Professor of Anesthesia, Beth Israel Deaconess Medical Center |
| ClinicalTrials.gov Identifier: | NCT04736212 |
| Other Study ID Numbers: |
2020P001209 |
| First Posted: | February 3, 2021 Key Record Dates |
| Last Update Posted: | September 24, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Respiratory Insufficiency Respiration Disorders Respiratory Tract Diseases |

